Charles River Laboratories Announces First-Quarter 2007 Results from Continuing Operations.

Extract

---

Charles River Laboratories Announces First-Quarter 2007 Results from Continuing Operations.

- First-Quarter Sales Increase 14.6% to $291 Million -

- First-Quarter GAAP EPS Increase 41% to $0.55 -

- First-Quarter Non-GAAP EPS Increase 33.3% to $0.64 -

- Reaffirms Guidance for 2007 -

WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) today reported first-quarter 2007 financial results. For the first quarter, net sales from continuing operations increased 14.6% to $291.2 million from $254.1 million in the first quarter of 2006. Strong sales growth in both the Research Models and Services and Preclinical Services business segments drove the increase, as pharmaceuti...

See the full content of this document

---